Carregant...
Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease
BACKGROUND: Indacaterol, a once-daily, long-acting β(2)-agonist, may improve not only respiratory function, dyspnea symptoms, and quality of life, but also physical activity for patients with chronic obstructive pulmonary disease (COPD). This study aimed to evaluate the effect of 12-week indacaterol...
Guardat en:
| Publicat a: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354394/ https://ncbi.nlm.nih.gov/pubmed/25767381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S76836 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|